Clinical features and MYO5B mutations of a family affected by microvillus inclusion disease.
- Author:
Ying CHENG
1
;
Hong LIANG
;
Na-Li CAI
;
Li GUO
;
Yu-Ge HUANG
;
Yuan-Zong SONG
Author Information
1. Department of Pediatrics, First Affiliated Hospital, Jinan University, Guangzhou 510630, China. songyuanzong@vip.tom.com.
- Publication Type:Journal Article
- MeSH:
Female;
Humans;
Infant, Newborn;
Malabsorption Syndromes;
diagnosis;
genetics;
Microvilli;
genetics;
pathology;
Mucolipidoses;
diagnosis;
genetics;
Mutation;
Myosin Heavy Chains;
genetics;
Myosin Type V;
genetics
- From:
Chinese Journal of Contemporary Pediatrics
2017;19(9):968-974
- CountryChina
- Language:Chinese
-
Abstract:
Microvillus inclusion disease (MVID) is an autosomal recessive disorder caused by biallelic mutations in the MYO5B or STX3 gene. Refractory diarrhea and malabsorption are the main clinical manifestations. The aim of this study was to investigate the clinical features and MYO5B gene mutations of an infant with MVID. A 21-day-old female infant was referred to the hospital with the complaint of diarrhea for 20 days. On physical examination, growth retardation of the body weight and length was found along with moderately jaundiced skin and sclera. Breath sounds were clear in the two lungs and the heart sounds were normal. The abdomen was distended and the veins in the abdominal wall were observed. The liver and spleen were not palpable. Biochemical analysis revealed raised serum total bile acids, bilirubin, transaminases and γ-glutamyl transpeptidase while decreased levels of serum sodium, chloride, phosphate and magnesium. Blood gas analysis indicated metabolic acidosis. The preliminary diagnosis was congenital diarrhea, and thus parenteral nutrition was given along with other symptomatic and supportive measures. However, diarrhea, metabolic acidosis and electrolyte disturbance were intractable, and the cholestatic indices, including transaminases, γ-glutamyl transpeptidase, bilirubin and total bile acids, remained at increased levels. One month later, the patient was discharged and then lost contact. On genetic analysis, the infant was proved to be a compound heterozygote of the c.310+2Tdup and c.1966C>T(p.R656C) variants of the gene MYO5B, with c.310+2Tdup being a novel splice-site mutation. MVID was thus definitely diagnosed.
